Sun Pharma, AstraZeneca tie up to sell latest anti-diabetes drug Dapagliflozin

Diabetes estimated to affect approximately 69.2 million people in India and more than 415 million people worldwide.

Source: The Economic Times Healthcare and Biotech News - March 23, 2016 Category: Pharmaceuticals Source Type: news